Dynamic straining combined with fibrin gel cell seeding improves strength of tissue-engineered small-diameter vascular grafts

Tissue Engineering - Part A

Volumn 15, Issue 5, 2009, Pages 1081-1089

  Stekelenburg, Maria ^a   Rutten, Marcel C M ^a   Snoeckx, Luc H E H ^b   Baaijens, Frank P T ^a  

^a EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSEL PROSTHESES; CELL CULTURE; GELATION; GELS; GENETIC ENGINEERING; GRAFTS; MECHANICAL PROPERTIES; NUCLEIC ACIDS; STRAIN; SYNCHROTRONS; TISSUE ENGINEERING;

4-HYDROXYBUTYRATE; BURST PRESSURES; CELL SEEDING; CORONARY BYPASS; DYNAMIC STRAIN; DYNAMIC STRAINING; FIBRIN GELS; GENE THERAPY; HUMAN TISSUES; IN-VITRO; MYOFIBROBLASTS; NATIVE COLLAGEN; POLY GLYCOLIC ACID; PRESSURE RANGES; SAPHENOUS VEIN; SMALL-DIAMETER; VASCULAR GRAFTS; VASCULAR TISSUE ENGINEERING;

BIOMECHANICS;

COLLAGEN; FIBRIN; HYDROXYBUTYRIC ACID; POLYGLYCOLIC ACID;

ADULT; AGED; ARTICLE; BLOOD VESSEL GRAFT; CELL CULTURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO SELECTION; MALE; MYOFIBROBLAST; PRIORITY JOURNAL; SAPHENOUS VEIN; TENSILE STRENGTH; TISSUE ENGINEERING;

EID: 66249118037     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2008.0183     Document Type: Article

References (36)

1. American Heart Association Heart Disease and Stroke Statistics-Update 2008. Available at: http://www.americanheart.org/presenter.jhtml?identifier= 3037327 [on-line]. Accessed on June 20, 2008.
2. Shapira I, Isakov A, Heller I, Topilsky M, Pines A. Long-term follow-up after coronary artery bypass grafting reoperation. Chest. 115, 1593, 1999.
3. Kidney and Urologic Diseases Statistics for the United States, 2003 [on-line]. Available at: http://kidney.niddk.nih.gov/kudiseases/pubs/kustats/ index.htm. Accessed on February 1, 2006.
4. Bordenave L, Fernandez P, Remy-Zolghadri M, Villars S, Daculsi R, Midy D. In vitro endothelialized ePTFE prostheses: clinical update 20 years after the first realization. Clin Hemorheol Microcirc. 33, 227, 2005.
5. Gong Z, Niklason LE. Blood vessels engineered from human cells. Trends Cardiovasc Med. 16, 153, 2006.
6. L'heureux N, Dusserre N, Konig G, Victor B, Keire P, Wight TN, Chronos NA, Kyles AE, Gregory CR, Hoyt G, Robbins RC, McAllister TN. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med. 12, 361, 2006.
7. Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, Marini R, Langer R. Functional arteries grown in vitro. Science. 284, 489, 1999.
8. Klinger RY, Blum JL, Hearn B, Lebow B, Niklason LE. Relevance and safety of telomerase for human tissue engineering. Proc Natl Acad Sci U S A. 103, 2500, 2006.
9. Poh M, Boyer M, Solan A, Dahl SL, Pedrotty D, Banik SS, McKee JA, Klinger RY, Counter CM, Niklason LE. Blood vessels engineered from human cells. Lancet. 365, 2122, 2005.
10. Mol A, Rutten MC, Driessen NJ, Bouten CV, Zund G, Baaijens FP, Hoerstrup SP. Human tissue-engineered heart valves: prospects for systemic application. Circulation. 114(1 Suppl), I152, 2006.
11. Hoerstrup SP, Zund G, Sodian R, Schnell AM, Grunenfelder J, Turina MI. Tissue engineering of small caliber vascular grafts. Eur J Cardiothorac Surg. 20, 164, 2001.
12. Schnell AM, Hoerstrup SP, Zund G, Kolb S, Sodian R, Visjager JF, Grunenfelder J, Suter A, Turina M. Optimal cell source for cardiovascular tissue engineering: venous vs. aortic human myofibroblasts. Thorac Cardiovasc Surg. 49, 221, 2001.
13. Mol A, van Lieshout MI, Dam-de Veen CG, Neuenschwander S, Hoerstrup SP, Baaijens FP, Bouten CV. Fibrin as a cell carrier in cardiovascular tissue engineering applications. Biomaterials. 26, 3113, 2005.
14. Cesarone CF, Bolognesi C, Santi L. Improved microfluorometric DNA determination in biological material using 33258 Hoechst. Anal Biochem. 100, 88, 1979.
15. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta. 883, 173, 1986.
16. Huszar G, Maiocco J, Naftolin F. Monitoring of collagen and collagen fragments in chromatography of protein mixtures. Anal Biochem. 105, 424, 1980.
17. Middleton J, Tipton A. Synthetic biodegradable polymers as medical devices. Med Plast Biomater Mag March/April, 31, 1998.
18. Berglund JD, Nerem RM, Sambanis A. Incorporation of intact elastin scaffolds in tissue-engineered collagen-based vascular grafts. Tissue Eng. 10, 1526, 2004.
19. Klouda L, Vaz CM, Mol A, Baaijens FP, Bouten CV. Effect of biomimetic conditions on mechanical and structural integrity of PGA/P4HB and electrospun PCL scaffolds. J Mater Sci Mater Med. 19, 1137, 2008.
20. Shin'oka T, Imai Y, Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 344, 532, 2001.
21. Shin'oka T, Matsumura G, Hibino N, Naito Y, Watanabe M, Konuma T, Sakamoto T, Nagatsu M, Kurosawa H. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg. 129, 1330, 2005.
22. L'Heureux N, Dusserre N, Konig G, Fuente L, Marini A, Avila H, Manglano X, Robbins RC, and Garrido S. American Heart Association's Scientific Sessions, Dallas, TX, abstract 2982, 2005.
23. Salacinski HJ, Goldner S, Giudiceandrea A, Hamilton G, Seifalian AM, Edwards A, Carson RJ. The mechanical behavior of vascular grafts: a review. J Biomater Appl. 15, 241, 2001.
24. Dahl SL, Rhim C, Song YC, Niklason LE. Mechanical properties and compositions of tissue engineered and native arteries. Ann Biomed Eng. 35, 348, 2007.
25. Clark RAF, Nielsen LD, Welch MP, McPherson JM. Collagen matrices attenuate the collagen-synthetic response of cultured fibroblasts to TGF-beta. J Cell Sci. 108, 1251, 1995.
26. Tuan T, Song A, Chang S, Younai S, Nimni M. In vitro fibroplasia: matrix contraction, cell growth, and collagen production of fibroblasts cultured in fibrin gels. Exp Cell Res. 223, 127, 1996.
27. Grassl ED, Oegema TR, Tranquillo RT. Fibrin as an alternative biopolymer to type-I collagen for the fabrication of a media equivalent. J Biomed Mater Res. 60, 607, 2002.
28. Ye Q, Zund G, Benedikt P, Jockenhoevel S, Hoerstrup SP, Sakyama S, Hubbell JA, Turina M. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg. 17, 587, 2000.
29. Rowe SL, Lee S, Stegemann JP. Influence of thrombin concentration on the mechanical and morphological properties of cell-seeded fibrin hydrogels. Acta Biomater. 3, 59, 2007.
30. Schmidt D, Asmis LM, Odermatt B, Kelm J, Breymann C, Gössi M, Genoni M, Zund G, Hoerstrup SP. Engineered living blood vessels: functional endothelia generated from human umbilical cord-derived progenitors. Ann Thorac Surg. 82, 1465, 2006.
31. Rasmussen LM, Ledet T. Aortic collagen alterations in human diabetes mellitus. Changes in basement membrane collagen content and in the susceptibility of total collagen to cyanogen bromide solubilisation. Diabetologia. 36, 445, 1993.
32. Mitchell SL, Niklason LE. Requirements for growing tissue-engineered vascular grafts. Cardiovasc Pathol. 12, 59, 2003.
33. Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha EA, Martin DP, Moran AM, Guleserian KJ, Sperling JS, Kaushal S, Vacanti JP, Schoen FJ, Mayer JE Jr. Functional living trileaflet heart valves grown in vitro. Circulation. 102, 44, 2000.
34. Lemson MS, Tordoir JH, Daemen MJ, Kitslaar PJ. Intimal hyperplasia in vascular grafts. Eur J Vasc Endovasc Surg. 19, 336, 2000.
35. L'Heureux N, Paquet S, Labbe R, Germain L, Auger FA. A completely biological tissue-engineered human blood vessel. FASEB J. 12, 47, 1998.
36. Yu A, Dardik H, Wolodiger F, Raccuia J, Kapadia I, Sussman B, Kahn M, Pecoraro JP, Ibrahim IM. Everted cervical vein for carotid patch angioplasty. J Vasc Surg. 12, 523, 1990.